Posted On: 08/05/2014 10:50:17 AM
Post# of 74542
$ACT Company News
Actavis raises guidance as earnings top views 8:11 a.m. Today - MarketWatch.com
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Leon Cooperman talks up Citi, Thermo Fisher 11:20 a.m. July 16, 2014 - Sue Chang
Leon Cooperman likes Thermo Fisher, Citi, Actavis 11:06 a.m. July 16, 2014 - Sue Chang
10 biggest S&P 500 winners and losers for 2014 10:44 a.m. July 1, 2014 - Philip van Doorn
Affiliated Managers Group to join S&P 500 5:33 p.m. June 24, 2014 - Wallace Witkowski
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis updates guidance after Q2 results 9:45 a.m. Today - Seeking Alpha
Why Akorn (AKRX) Stock Is Advancing Today 8:26 a.m. Today - TheStreet.com
UPDATE: Actavis Posts Upbeat Q2 Earnings, Raises Forecast 8:25 a.m. Today - benzinga.com
Today's Pre-Market Laggard Is Actavis (ACT) 8:25 a.m. Today - TheStreet.com
Actavis Swings to Profit 8:09 a.m. Today - The Wall Street Journal Interactive Edition
Wall Street Breakfast: AIG Settles Crisis-Era Lawsuit And Posts Profit 6:34 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: ACT AMZN CAH AAPL 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - 4 Charts With Fangs (8/4/14) 5:52 a.m. Today - Seeking Alpha
Akorn receives FTC approval to acquire VersaPharm 1:53 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Watch Your Back 7:59 p.m. Aug. 4, 2014 - TheStreet.com
Notable earnings before Tuesday's open 5:30 p.m. Aug. 4, 2014 - Seeking Alpha
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Aug. 4, 2014 - TheStreet.com
Why Actavis (ACT) Might Surprise This Earnings Season - Tale of the Tape 8:36 a.m. Aug. 4, 2014 - Zacks.com
Billionaire Leon Cooperman Delivers Alpha Again 3:13 a.m. Aug. 2, 2014 - Seeking Alpha
Endo International Beats on Q2 Earnings & Sales, Guidance Up - Analyst Blog 3:36 p.m. Aug. 1, 2014 - Zacks.com
3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP 11:44 a.m. July 31, 2014 - Zacks.com
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds 2:38 p.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
UPDATE: Bank Of America Reiterates On Actavis plc On Strong Strategic/Financial Position 9:54 a.m. July 29, 2014 - benzinga.com
Actavis May Give Buyers Another Chance 5:03 p.m. July 28, 2014 - Investors Business Daily
Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 7:00 a.m. Today - PR Newswire - PRF
Earnings Releases, Technical Updates, FDA Acceptances, and New Products - Research Reports on Newfield Exploration, YPF, HCA, Actavis and 3M 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD 4:30 p.m. July 21, 2014 - PR Newswire - PRF
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Actavis Confirms Generic Diclegis® Patent Challenge 4:25 p.m. July 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Ampyra® Patent Challenge 4:05 p.m. July 8, 2014 - PR Newswire - PRF
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Impax Acquires Two Products from Actavis 4:05 p.m. July 2, 2014 - PR Newswire - PRF
Actavis Completes Acquisition of Furiex Pharmaceuticals 8:46 a.m. July 2, 2014 - PR Newswire - PRF
Actavis Announces Final Stockholder Merger Consideration Election Results in Connection with Forest Laboratories Acquisition 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger 3:15 p.m. July 1, 2014 - BusinessWire - BZX
Fitch Rates Forest Labs Bonds 'BBB-', Affirms Actavis at 'BBB-'; Outlook Stable 10:08 a.m. July 1, 2014 - BusinessWire - BZX
Actavis plc Appoints New Members and Announces Changes to Board of Directors Following Close of Forest Laboratories, Inc. Acquisition 9:00 a.m. July 1, 2014 - PR Newswire - PRF
Actavis Completes Forest Laboratories Acquisition 8:20 a.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - PR Newswire - PRF
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - PR Newswire - PRF
Actavis to Host Second Quarter 2014 Earnings Conference Call and Webcast 8:00 a.m. June 30, 2014 - PR Newswire - PRF
Actavis raises guidance as earnings top views 8:11 a.m. Today - MarketWatch.com
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Leon Cooperman talks up Citi, Thermo Fisher 11:20 a.m. July 16, 2014 - Sue Chang
Leon Cooperman likes Thermo Fisher, Citi, Actavis 11:06 a.m. July 16, 2014 - Sue Chang
10 biggest S&P 500 winners and losers for 2014 10:44 a.m. July 1, 2014 - Philip van Doorn
Affiliated Managers Group to join S&P 500 5:33 p.m. June 24, 2014 - Wallace Witkowski
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis updates guidance after Q2 results 9:45 a.m. Today - Seeking Alpha
Why Akorn (AKRX) Stock Is Advancing Today 8:26 a.m. Today - TheStreet.com
UPDATE: Actavis Posts Upbeat Q2 Earnings, Raises Forecast 8:25 a.m. Today - benzinga.com
Today's Pre-Market Laggard Is Actavis (ACT) 8:25 a.m. Today - TheStreet.com
Actavis Swings to Profit 8:09 a.m. Today - The Wall Street Journal Interactive Edition
Wall Street Breakfast: AIG Settles Crisis-Era Lawsuit And Posts Profit 6:34 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: ACT AMZN CAH AAPL 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - 4 Charts With Fangs (8/4/14) 5:52 a.m. Today - Seeking Alpha
Akorn receives FTC approval to acquire VersaPharm 1:53 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Watch Your Back 7:59 p.m. Aug. 4, 2014 - TheStreet.com
Notable earnings before Tuesday's open 5:30 p.m. Aug. 4, 2014 - Seeking Alpha
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Aug. 4, 2014 - TheStreet.com
Why Actavis (ACT) Might Surprise This Earnings Season - Tale of the Tape 8:36 a.m. Aug. 4, 2014 - Zacks.com
Billionaire Leon Cooperman Delivers Alpha Again 3:13 a.m. Aug. 2, 2014 - Seeking Alpha
Endo International Beats on Q2 Earnings & Sales, Guidance Up - Analyst Blog 3:36 p.m. Aug. 1, 2014 - Zacks.com
3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP 11:44 a.m. July 31, 2014 - Zacks.com
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds 2:38 p.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
UPDATE: Bank Of America Reiterates On Actavis plc On Strong Strategic/Financial Position 9:54 a.m. July 29, 2014 - benzinga.com
Actavis May Give Buyers Another Chance 5:03 p.m. July 28, 2014 - Investors Business Daily
Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 7:00 a.m. Today - PR Newswire - PRF
Earnings Releases, Technical Updates, FDA Acceptances, and New Products - Research Reports on Newfield Exploration, YPF, HCA, Actavis and 3M 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD 4:30 p.m. July 21, 2014 - PR Newswire - PRF
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Actavis Confirms Generic Diclegis® Patent Challenge 4:25 p.m. July 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Ampyra® Patent Challenge 4:05 p.m. July 8, 2014 - PR Newswire - PRF
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Impax Acquires Two Products from Actavis 4:05 p.m. July 2, 2014 - PR Newswire - PRF
Actavis Completes Acquisition of Furiex Pharmaceuticals 8:46 a.m. July 2, 2014 - PR Newswire - PRF
Actavis Announces Final Stockholder Merger Consideration Election Results in Connection with Forest Laboratories Acquisition 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger 3:15 p.m. July 1, 2014 - BusinessWire - BZX
Fitch Rates Forest Labs Bonds 'BBB-', Affirms Actavis at 'BBB-'; Outlook Stable 10:08 a.m. July 1, 2014 - BusinessWire - BZX
Actavis plc Appoints New Members and Announces Changes to Board of Directors Following Close of Forest Laboratories, Inc. Acquisition 9:00 a.m. July 1, 2014 - PR Newswire - PRF
Actavis Completes Forest Laboratories Acquisition 8:20 a.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - PR Newswire - PRF
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - PR Newswire - PRF
Actavis to Host Second Quarter 2014 Earnings Conference Call and Webcast 8:00 a.m. June 30, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼
